BSE Live
Oct 01, 16:01Prev. Close
291.50
Open Price
297.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Balance Sheet of Samrat Pharmachem (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | |
Total Share Capital | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | |
Reserves and Surplus | 68.71 | 61.91 | 60.05 | 43.73 | 26.55 | |
Total Reserves and Surplus | 68.71 | 61.91 | 60.05 | 43.73 | 26.55 | |
Total Shareholders Funds | 71.80 | 65.00 | 63.14 | 46.82 | 29.64 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 0.11 | 0.34 | 0.25 | 0.46 | 0.43 | |
Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 0.11 | 0.34 | 0.25 | 0.46 | 0.43 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 9.91 | 8.45 | 18.66 | 7.52 | 8.79 | |
Trade Payables | 38.56 | 47.67 | 31.96 | 23.34 | 17.66 | |
Other Current Liabilities | 1.08 | 0.28 | 2.14 | 0.88 | 0.17 | |
Short Term Provisions | 0.02 | 0.00 | 0.00 | 5.59 | 0.70 | |
Total Current Liabilities | 49.58 | 56.40 | 52.75 | 37.33 | 27.33 | |
Total Capital And Liabilities | 121.49 | 121.74 | 116.15 | 84.61 | 57.40 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 10.47 | 10.72 | 10.70 | 9.98 | 9.39 | |
Intangible Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 10.48 | 10.72 | 10.70 | 9.99 | 9.40 | |
Non-Current Investments | 3.44 | 2.92 | 1.86 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.27 | 0.28 | 0.24 | 0.21 | 0.20 | |
Other Non-Current Assets | 3.94 | 5.25 | 4.73 | 0.60 | 0.46 | |
Total Non-Current Assets | 18.13 | 19.17 | 17.54 | 10.79 | 10.07 | |
CURRENT ASSETS | ||||||
Current Investments | 0.36 | 0.01 | 0.01 | 0.01 | 0.00 | |
Inventories | 38.01 | 20.68 | 32.53 | 12.42 | 11.40 | |
Trade Receivables | 56.54 | 69.28 | 51.24 | 43.57 | 33.01 | |
Cash And Cash Equivalents | 0.16 | 9.73 | 11.89 | 17.27 | 2.54 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | |
OtherCurrentAssets | 8.30 | 2.88 | 2.95 | 0.54 | 0.36 | |
Total Current Assets | 103.36 | 102.57 | 98.62 | 73.82 | 47.32 | |
Total Assets | 121.49 | 121.74 | 116.15 | 84.61 | 57.40 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 0.07 | 0.07 | 0.07 | 0.07 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 133.42 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 235.04 | 258.67 | 152.78 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | 5.75 | 12.68 | 10.73 | 13.66 | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | 0.01 | 0.01 | 0.01 | 0.00 | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
10.06.2025
Samrat Pharma Standalone March 2025 Net Sales at Rs 71.20 crore, down 13.88% Y-o-Y
25.11.2024
Samrat Pharma Standalone September 2024 Net Sales at Rs 70.17 crore, down 12% Y-o-Y
17.08.2024
Samrat Pharma Standalone June 2024 Net Sales at Rs 80.82 crore, up 40.61% Y-o-Y
07.06.2024
Samrat Pharma Standalone March 2024 Net Sales at Rs 82.68 crore, up 19.52% Y-o-Y
10.06.2025
Samrat Pharma Standalone March 2025 Net Sales at Rs 71.20 crore, down 13.88% Y-o-Y
25.11.2024
Samrat Pharma Standalone September 2024 Net Sales at Rs 70.17 crore, down 12% Y-o-Y
17.08.2024
Samrat Pharma Standalone June 2024 Net Sales at Rs 80.82 crore, up 40.61% Y-o-Y
07.06.2024
Samrat Pharma Standalone March 2024 Net Sales at Rs 82.68 crore, up 19.52% Y-o-Y